Retina Consultants of Texas

Bellaire, Texas 77401

11 studies enrolling now · 56 studies all time

What they study most

Age - Related Macular Degeneration (AMD), Age Related Macular Degeneration (ARMD), Age-Related Macular Degeneration, Age-Related Macular Degeneration (AMD), Age-related Macular Degeneration, Choroidal Melanoma, Choroidal Neovascularization, DME, Diabetic Macular Edema, Diabetic Macular Edema (DME), Diabetic Retinopathy, Dry Age-related Macular Degeneration

Studies at this site

• A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) — Recruiting now
• CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME — Recruiting now
• Extension Study for the Port Delivery System With Ranibizumab (Portal) — Recruiting now
• A Study of AAVB-039 in Participants With Stargardt Disease (STGD1) — Recruiting now
• Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD — Recruiting now
• Randomized Trial Comparing Immediate vs. Deferred Surgery for Symptomatic ERM — Recruiting now
• A Study to Optimize Subretinal Surgical Delivery and to Evaluate Safety and Activity of Opregen in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (GAlette); Adaptive Optics (AO) Retinal Imaging Substudy in Association With Study GR44251 — Recruiting now
• A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS) — Recruiting now
• Suprachoroidal Administration in Subjects With Metastases to the Choroid — Recruiting now
• A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa — Running, not enrolling
• A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease — Running, not enrolling
• Global Patient Registry of Inherited Retinal Diseases — Running, not enrolling
• Long-Term Follow Up of VOY-101 Non-nAMD Extension Study — Enrolling by invitation
• An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration — Running, not enrolling
• Study to Evaluate an 8 mg Aflibercept (EYLEA®) Prefilled Syringe (PFS) — Completed
• A Study in Adults With Geographic Atrophy — Starting soon
• ReNEW:Phase 3 Study of Efficacy, Safety & Pharmacokinetics of Subcutaneous Injections of Elamipretide in Subjects With Dry Age-Related Macular Degeneration (Dry AMD) — Running, not enrolling
• A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema — Completed
• Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration — Running, not enrolling
• A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA) — Running, not enrolling
• A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2) — Completed
• A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK — Running, not enrolling
• Vamikibart in Participants With Uveitic Macular Edema — Completed
• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP — Running, not enrolling
• Safety and Efficacy of Faricimab in Patients With NPDR — Completed
• High Dose Eylea for Proliferative Diabetic Retinopathy Outcomes — Running, not enrolling
• A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Diabetic Macular Edema — Completed
• NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration — Running, not enrolling
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema — Running, not enrolling
• Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration — Running, not enrolling
• A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema (YOSEMITE) — Completed
• A Study to Evaluate the Efficacy and Safety of Faricimab (RO6867461) in Participants With Diabetic Macular Edema — Completed
• A Study to Determine the Safety and Efficacy of NT-501 With MHFM — Running, not enrolling
• Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration (i-SIGHT) — Completed
• Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration — Running, not enrolling
• Retina BioBank: Retina Biomarkers for a Deeper Understanding of Vitreoretinal and Systemic Diseases — Enrolling by invitation
• Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema — Stopped early
• Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial — Completed
• Safety and Efficacy of AM712 in Patients with NAMD — Completed
• Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion — Completed
• A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment — Completed
• A Study to Test Different Doses of BI 836880 in Patients With an Eye Disease Called Wet Age-related Macular Degeneration (wAMD) — Completed
• A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol B — Completed
• Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of KSI-301, an Anti-VEGF Antibody Biopolymer Conjugate, Versus Aflibercept in Patients With Neovascular (Wet) Age-Related Macular Degeneration. — Stopped early
• HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia — Completed
• Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration — Status unconfirmed
• Exploratory Study to Investigate the Bioactivity, Ocular and Systemic Safety, Tolerability, and Pharmacokinetics Following Single and Multiple Intravitreal Administrations of KSI-301 in Subjects With wAMD, DME and RVO — Stopped early
• Serine and Fenofibrate Study in Patients With MacTel Type 2 — Running, not enrolling